Ephedrine
Stimulant, Habit-forming
Ephedrine is a sympathomimetic amine commonly used as a stimulant, concentration aid, decongestant, appetite suppressant, and to treat hypotension associated with anaesthesia. A methamphetamine analogue and commonly used in the production of methamphetamine.
Tachycardia, cardiac arrhythmias, angina pectoris, vasoconstriction with hypertension, flushing, sweating, acne vulgaris, nausea, decreased urination, difficulty urinating, restlessness, confusion, insomnia, mild euphoria, mania/hallucinations, delusions, formication, dyspnea, pulmonary edema, dizziness, headache, tremor, hyperglycemic reactions, and dry mouth
Closed-angle glaucoma, phaeochromocytoma, asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis), concomitant or recent (previous 14 days) monoamine oxidase inhibitor (MAOI) therapy, general anaesthesia with halogenated hydrocarbons (particularly halothane), tachyarrhythmias or ventricular fibrillation, and hypersensitivity to ephedrine or other stimulants.
Australia: Prescription Only (S4) | Canada: Schedule VI | United Kingdom: P | United States: List I OTC
Bioavailability: 85% | Metabolism: minimal hepatic | Excretion: 22 - 99% renal
NDRA (Norepinephrine-Dopamine Releasing Agent)
Chart shows bounded mass ranges in mg. See the table for all doses.
Threshold
Light
Common
Strong
Heavy
Oral
5-10mg
10-20mg
20-30mg
30-50mg
50mg+
Onset
Duration
After Effects
Oral
5m to 20m
0 to 3
1 to 8